Seeing Is Believing
Currently out of the existing stock ratings of James Sidoti, 14 are a BUY (77.78%), 4 are a HOLD (22.22%).
Analyst James Sidoti, currently employed at SIDOTI, carries an average stock price target met ratio of 51.39% that have a potential upside of 17.08% achieved within 76 days.
James Sidoti’s has documented 35 price targets and ratings displayed on 6 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on ANIK, Anika Therapeutics at 09-Aug-2023.
Analyst best performing recommendations are on CUTR (CUTERA).
The best stock recommendation documented was for CUTR (CUTERA) at 7/6/2017. The price target of $32 was fulfilled within 33 days with a profit of $5.65 (21.44%) receiving and performance score of 6.5.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$1.5
$0.44 (41.51%)
$1.5
10 days ago
(11-Nov-2024)
3/20 (15%)
$0.32 (27.12%)
25
Hold
$3
$1.94 (183.02%)
$2
1 years 8 days ago
(13-Nov-2023)
1/5 (20%)
$1.85 (160.87%)
318
Hold
$5
$3.94 (371.70%)
$14
2 years 3 months 9 days ago
(12-Aug-2022)
0/2 (0%)
$0.52 (11.61%)
Buy
$30
3 years 7 months 23 days ago
(29-Mar-2021)
1/1 (100%)
$11.42 (61.46%)
75
What Year was the first public recommendation made by James Sidoti?